Goldman Sachs Group Inc Kronos Bio, Inc. Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 17,785 shares of KRON stock, worth $17,251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,785
Previous 17,895
0.61%
Holding current value
$17,251
Previous $23,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding KRON
# of Institutions
59Shares Held
20.7MCall Options Held
31.4KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$2.68 Million3.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.87 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.86MShares$1.8 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.67MShares$1.62 Million0.04% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.4 Million0.11% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $55.1M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...